Back to top

Consent Regarding Loan and Security Agreement

Security Agreement

Consent Regarding Loan and Security Agreement | Document Parties: EV3 ENDOVASCULAR, INC | EV3 INTERNATIONAL, INC | FOXHOLLOW TECHNOLOGIES, INC | Micro Therapeutics International, Inc | MICRO THERAPEUTICS, INC | Peripheral, Inc | SILICON VALLEY BANK You are currently viewing:
This Security Agreement involves

EV3 ENDOVASCULAR, INC | EV3 INTERNATIONAL, INC | FOXHOLLOW TECHNOLOGIES, INC | Micro Therapeutics International, Inc | MICRO THERAPEUTICS, INC | Peripheral, Inc | SILICON VALLEY BANK

. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here.
Title: Consent Regarding Loan and Security Agreement
Date: 8/3/2009
Industry: Medical Equipment and Supplies     Sector: Healthcare

Consent Regarding Loan and Security Agreement, Parties: ev3 endovascular  inc , ev3 international  inc , foxhollow technologies  inc , micro therapeutics international  inc , micro therapeutics  inc , peripheral  inc , silicon valley bank
50 of the Top 250 law firms use our Products every day

Exhibit 10.2

Consent
Regarding
Loan and Security Agreement

      THIS CONSENT Regarding Loan and Security Agreement (this “Consent”) is entered into as of June 19, 2009, by and between SILICON VALLEY BANK (“Bank”), on the one side, and

      EV3 ENDOVASCULAR, INC. , a Delaware corporation,

      EV3 INTERNATIONAL, INC. , a Delaware corporation,

      MICRO THERAPEUTICS, INC. , a Delaware corporation, and

      FOXHOLLOW TECHNOLOGIES, INC. , a Delaware corporation

(collectively and jointly and severally referred to as “ Borrowers ”), whose address is c/o ev3 Inc., 9600 54 th Avenue North, Plymouth, MN 55442, on the other side.

Recitals

      A.  Bank and Borrowers have entered into that certain Loan and Security Agreement dated as of an Effective Date of June 28, 2006 (as the same may from time to time be further amended, modified, supplemented or restated, the “Loan Agreement”). The Obligations of the Borrowers have been guarantied by, among others, the following companies, in favor of Bank: ev3 Inc., a Delaware corporation; Micro Therapeutics International, Inc., a Delaware corporation; and ev3 Peripheral, Inc., a Minnesota corporation (collectively, the “Guarantors”).

      B.  Bank has extended credit to Borrowers for the purposes permitted in the Loan Agreement.

      C.  Borrowers have requested that Bank (i) consent to the Chestnut Merger (as defined below), and (ii) make certain other revisions to the Loan Agreement, all as more fully set forth herein.

      D.  Bank has agreed to provide a consent and to so amend certain provisions of the Loan Agreement, but only to the extent, in accordance with the terms, subject to the conditions and in reliance upon the representations and warranties set forth below.

Agreement

      Now, Therefore, in consideration of the foregoing recitals and other good and valuable consideration, the receipt and adequacy of which is hereby acknowledged, and intending to be legally bound, the parties hereto agree as follows:

 


 

      1. Definitions. Capitalized terms used but not defined in this Consent shall have the meanings given to them in the Loan Agreement.

      2. Consent to Merger. Borrowers have advised Bank that (a) Parent has entered into an agreement and plan of merger whereby Starsky Merger Sub, Inc., a California corporation and a direct wholly owned subsidiary of Parent, will merge with and into Chestnut Medical Technologies, Inc., a California corporation (“Chestnut Medical”), with Chestnut Medical being the surviving corporation, and, immediately subsequent to such merger, Chestnut Medical will merge with and into Starsky Acquisition Sub, Inc., a California corporation and a direct wholly owned subsidiary of Parent (“Merger Subsidiary”), with Merger Subsidiary being the surviving corporation (such mergers being collectively referred to as the “Chestnut Mergers”), and (b) the total consideration for the acquisition of Chestnut Medical by virtue of the Chestnut Mergers shall be a maximum of $150,000,000 to be structured as follows:

An amount equal to $75,000,000 will be payable by Parent at closing of the Chestnut Mergers, with 50% to be paid in cash and the remaining amount in Parent stock; and

Upon receiving a FDA pre-market approval letter (“PMA letter”) for securing an indication to treat intracranial aneurysms and to commercialize the Chestnut Medical Pipeline device in the United States, a second payment by Parent will be structured as follows: $75,000,000 (split 50/50 between cash and Parent stock) provided that (y) if the PMA letter is not received by October 1, 2011, the $75,000,000 payment will decrease by $3,750,000 per month and will decrease to zero if the PMA letter is not received by December 31, 2012, and (z) if the following conditions are not satisfied, Parent will be able to defer up to $30,000,000 of the cash portion of the payment for 12 months: (A) Parent has a minimum cash balance of $75,000,000 at the time the PMA letter is received, (B) making the payment would not result in an Event of Default under the Loan Documents, and (C) the payment would not be viewed as materially adverse to the business.

Parent and Borrowers have requested that, in accordance with Sections 7.3 and 7.7(a) of the Loan Agreement, Bank consent to the Chestnut Mergers, and, in reliance on the representations, warranties and covenants contained herein, Bank hereby consents to the Chestnut Mergers, upon the conditions that (which conditions Borrowers agree to satisfy) (i) concurrently herewith Merger Subsidiary shall grant to Bank a security interest in all of its “Collateral” (defined herein as defined in the Loan Agreement except that references in such definition to Borrower shall instead be to Merger Subsidiary) to secure all of the Obligations pursuant to a writing acceptable to Bank, (ii) immediately after the consummation of the Chestnut Mergers, Bank shall have a first-priority, perfected, security interest in all of the Collateral of Merger Subsidiary, and such Collateral shall be subject to no security interests or Liens other than Permitted Liens, and (iii) the Chestnut Mergers are consummated on or before July 31, 2009. This consent does not constitute a waiver of any of the other terms or provisions of the Loan Agreement, or any other Loan Documents, or any other agreement, document or instrument providing rights in favor of

2


 

Bank, nor does it constitute a consent to any other transaction or event, whether or not similar to the foregoing, and whether or not related to any of the transactions or events referred to herein. For purposes of clarity and without limitation on the generality of the foregoing limitations on Bank’s consent, Borrowers acknowledge that Bank is not consenting to any breach of any financial covenant that may be contained in the Loan Documents that may result from the Chestnut Mergers.

      3. New Guarantor. Borrowers agree to cause the following to occur within 30 days of the consummation of the Chestnut Mergers:

           a. Merger Subsidiary shall become a Guarantor of the Obligations by executing a continuing guaranty in favor of Bank, and shall execute a security agreement in favor of Bank, in each case in the same form and substance as has been executed by the other Guarantors.

           b. Merger Subsidiary, Borrowers and Guarantors shall execute such documents, and take such actions, as Bank shall reasonably request, in order that the agreements and other documentation that effectuates Merger Subsidiary becoming a secured Guarantor shall be the same as that for the other Guarantors.

           c. Merger Subsidiary’s organizational documents shall not prohibit or limit Merger Subsidiary becoming a Guarantor or providing the security interest contemplated herein.

      4. Further Mergers of Merger Subsidiary.

           4.1 Section 7.3 (Mergers or Acquisitions). Notwithstanding and without limitation upon Section 7.3 of the Loan Agreement, after the consummation of the Chestnut Mergers, Merger Subsidiary shall not merge into any Borrower or Secured Guarantor unless Bank has consented in writing.

      5. Limitation on Consent and Amendments

           5.1 The consents and amendments set forth herein are effective for the purposes set forth herein and shall be limited precisely as written and shall not be deemed to (a) be a consent to any other transaction or to any amendment, waiver or modification of any other term or condition of any Loan Document, or (b) otherwise prejudice any right or remedy which Bank may now have or may have in the future under or in connection with any Loan Document.

           5.2 This Consent shall be construed in connection with and as part of the Loan Documents and all terms, conditions, representations, warranties, covenants and agreements set forth in the Loan Documents, except as herein amended, are hereby ratified and confirmed, shall remain in full force and effect, and are incorporated herein by reference.

3


 

      6. Representations and Warranties. To induce Bank to enter into this Consent, each Borrower hereby represents and warrants to Bank as follows:

           6.1 Immediately after giving effect to this Consent (a) the representations and warranties contained in the Loan Documents are true, accurate and complete in all material respects as of the date hereof (except to the extent such representations and warranties relate to an earlier date, in which case they are true and correct as of such date), and (b) no Event of Default has occurred and is continuing;

           6.2 Borrower has the power and authority to execute and deliver this Consent and to perform its obligations under the Loan Agreement, as amended or supplemented by this Consent;

           6.3 The organizational documents of Borrower previously delivered to Bank remain true, accurate and complete and have not been amended, supplemented or restated and are and continue to be in full force and effect except for the amendment to Parent’s Amended and Restated Certificate of Incorporation filed with the SEC as an exhibit to Form 8-K on July 23, 2007, a copy of which has been provided to Bank marked to show the differences from the certificate of incorporation of Parent that was in effect as of June 21, 2005;

           6.4 The execution and delivery by Borrower of this Consent and the


 
SITE SEARCH

AGREEMENTS / CONTRACTS

Document Title:

Entire Document: (optional)

Governing Law:(optional)


Try our advanced search >>
 

CLAUSES

Search Contract Clauses >>

Browse Contract Clause Library>>

Get Email Updates
Email:
This is only a partial view of this document. We have millions of legal documents and clauses drafted by top law firms. learn more search for free browse for free learn more